Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 96Stomach Neoplasms 53Rectal Neoplasms 49Pancreatic Neoplasms 42Colonic Neoplasms 34Esophageal Neoplasms 30Neoplasm Metastasis 28Neoplasms 23Adenocarcinoma Of Esophagus 19Adenocarcinoma 9Parkinson Disease 4, Autosomal Dominant Lewy Body 7Lymphoma, Large B-Cell, Diffuse 7Gallbladder Neoplasms 7Biliary Tract Neoplasms 7Esophageal Squamous Cell Carcinoma 6Carcinoma, Non-Small-Cell Lung 6Ovarian Neoplasms 5Liver Neoplasms 5Head and Neck Neoplasms 5Cholangiocarcinoma 5Recurrence 4Lymphoma, Non-Hodgkin 4Gastrointestinal Neoplasms 4Carcinoma, Hepatocellular 4Breast Neoplasms 4Bile Duct Neoplasms 4Peritoneal Neoplasms 3Pancreatic Adenocarcinoma 3Leukemia 3Fallopian Tube Neoplasms 3

Interventions

Gemcitabine 4pembrolizumab 2Leucovorin 2Irinotecan 2Fluorouracil 2Albumin-Bound Paclitaxel 24-fluorobenzoyl-TN-14003 2regorafenib 1olaparib 1irinotecan sucrosofate 1ibrutinib 1adavosertib 1Paclitaxel 1PEGPH20 1Oxaliplatin 1Drug Therapy 1Docetaxel 1Cisplatin 1Capecitabine 1BKT140 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Metastatic Pancreatic Adenocarcinoma × Oxaliplatin × Clear all
NCT01959139 2024-02-09

S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer

SWOG Cancer Research Network

Phase 1/2 Completed
126 enrolled 19 charts
Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡